Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.65 |
| ▸ | CES1 | P23141 | 1/20 | 0.65 |
| ▸ | NPC1 | O15118 | 6/20 | 0.63 |
| ▸ | RAB9A | P51151 | 6/20 | 0.63 |
| ▸ | PARP1 | P09874 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.59 |
| ▸ | ESR1 | P03372 | 1/20 | 0.59 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 5/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.57 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.56 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.56 |
| ▸ | MAOB | P27338 | 1/20 | 0.56 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30393680 | 0.94 | CES2 (0.71) | CES2CES1NPC1RAB9APARP1 | |
| SCHEMBL447346 | 0.94 | CES2 (0.71) | CES2CES1NPC1RAB9APARP1 | |
| SCHEMBL7652880 | 0.89 | CES2 (0.65) | CES2CES1NPC1RAB9APARP1 | |
| SCHEMBL11254925 | 0.87 | CES2 (0.62) | CES2CES1NPC1RAB9APARP1 | |
| SCHEMBL27744379 | 0.86 | ESR1 (0.73) | CES2CES1NPC1RAB9APARP1 | |
| SCHEMBL28519972 | 0.86 | ESR1 (0.73) | CES2CES1NPC1RAB9APARP1 | |
| SCHEMBL5279551 | 0.86 | CES2 (0.65) | CES2CES1NPC1RAB9APARP1 | |
| SCHEMBL6938784 | 0.84 | AKR1C3 (0.70) | NPC1SMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL28557620 | 0.84 | KMT2A (0.61) | ESR1ESR2MEN1KMT2AALDH1A1 | |
| Methyl 3-Methoxybenzoate SCHEMBL384913 | 0.83 | SMN1; SMN2 (0.73) | CES2CES1NPC1RAB9APARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260138947-A1 | BENZYLTRYPTAMINE COMPOUNDS | REUNION NEUROSCIENCE INC (US) | 2026-05-21 | — | — | US | disclosed |
| CN-118382614-A | Novel benzyl tryptamine compounds | 瑞安神经科学公司 | 2024-07-23 | — | — | CN | disclosed |
| WO-2023070228-A1 | NOVEL BENZYLTRYPTAMINE COMPOUNDS | REUNION NEUROSCIENCE CANADA INC. (CA) | 2023-05-04 | — | — | WO | disclosed |
| US-9290868-B2 | Biodegradable nonwoven fabric and fiber product using the same | JNC CORPORATION (JP) | 2016-03-22 | — | — | US | disclosed |
| CN-104098524-A | 1-m-methoxy benzoyl-3-phenyl-1, 4-dihydro-1,2,4,5-tetrazine and preparation and application thereof | UNIV ZHEJIANG TECHNOLOGY | 2014-10-15 | — | — | CN | disclosed |
| EP-2422005-B1 | BIODEGRADABLE NONWOVEN FABRIC AND FIBER PRODUCT USING THE SAME | JNC CORP (JP) | 2013-12-04 | — | — | EP | disclosed |
| US-20120064789-A1 | BIODEGRADABLE NONWOVEN FABRIC AND FIBER PRODUCT USING THE SAME | JNC CORPORATION (JP) | 2012-03-15 | — | — | US | disclosed |
| EP-2422005-A1 | BIODEGRADABLE NONWOVEN FABRIC AND FIBER PRODUCT USING THE SAME | JNC Corporation (JP) | 2012-02-29 | — | — | EP | disclosed |
| WO-2010122806-A1 | BIODEGRADABLE NONWOVEN FABRIC AND FIBER PRODUCT USING THE SAME | CHISSO CORPORATION (JP) | 2010-10-28 | — | — | WO | disclosed |
| US-7235559-B1 | Therapeutic quinazoline derivatives | ASTRAZENECA AB (SE) | 2007-06-26 | — | — | US | disclosed |
| EP-1218355-A1 | THERAPEUTIC QUINAZOLINE DERIVATIVES | AstraZeneca AB (SE) | 2002-07-03 | — | — | EP | disclosed |
| WO-2001021597-A1 | THERAPEUTIC QUINAZOLINE DERIVATIVES | ASTRAZENECA AB (SE) | 2001-03-29 | — | — | WO | disclosed |
| US-6153794-A | Phosphine sulfide, a manufacturing process therefor and use thereof | MITSUI CHEMICALS, INC. (JP) | 2000-11-28 | — | — | US | disclosed |
| CN-1262276-A | Phosphine sulfide preparing process and use thereof | MITSUI CHEMICALS INC (JP) | 2000-08-09 | — | — | CN | disclosed |
| EP-0972776-A1 | A phosphine sulfide, a manufacturing process therefor and a use thereof | Mitsui Chemicals, Inc. (JP) | 2000-01-19 | — | — | EP | disclosed |
| US-5837726-A | Antifungal agents derived from aspergillus fumigatus | MILLENNIUM PHARMACEUTICALS, INC. (US) | 1998-11-17 | — | — | US | disclosed |
| US-5451585-A | GABA=gamma-aminobutyric acid | NEUROGEN CORPORATION (US) | 1995-09-19 | — | — | US | disclosed |
| US-5312822-A | Gamma-aminobutyric acid | NEUROGEN CORPORATION (US) | 1994-05-17 | — | — | US | disclosed |
| US-5182290-A | Interaction with gamma-aminobutyric acid binding sites | NEUROGEN CORPORATION (US) | 1993-01-26 | — | — | US | disclosed |
| US-3970671-A | XANTHENE, PRESSURE SENSITIVE | KANZAKI PAPER MANUFACTURING CO., LTD. (JA) | 1976-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260138947-A1 | BENZYLTRYPTAMINE COMPOUNDS | HTR2C, CNR2, HTR3B | CES2 136/4885CES1 1038/4885NPC1 1416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.